Cargando…
Cardiovascular Damage in COVID-19: What We Know Two Years Later
PURPOSE OF THE REVIEW: The Coronavirus disease 2019 (COVID-19) pandemic has profoundly influenced cardiological clinical and basic research in the past two years. In the present review, we summarize the current knowledge on myocardial involvement in COVID-19, providing an overview on the incidence,...
Autores principales: | Nuzzi, Vincenzo, Del Mestre, Eva, Degrassi, Alessia, Bromage, Daniel I., Manca, Paolo, Piper, Susan, Artico, Jessica, Gentile, Piero, Scott, Paul A., Chiatto, Mario, Merlo, Marco, Pareek, Nilesh, Giacca, Mauro, Sinagra, Gianfranco, McDonagh, Theresa A., Cannata, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244358/ https://www.ncbi.nlm.nih.gov/pubmed/35751835 http://dx.doi.org/10.1007/s11886-022-01730-4 |
Ejemplares similares
-
Treatment of Iron Deficiency in Heart Failure
por: Shamsi, Aamir, et al.
Publicado: (2023) -
State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
por: Ammirati, Enrico, et al.
Publicado: (2022) -
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction
por: Del Buono, Marco Giuseppe, et al.
Publicado: (2022) -
Imaging-Guided Treatment for Cardiac Amyloidosis
por: Ioannou, Adam, et al.
Publicado: (2022) -
Towards a New Classification of Cardiomyopathies
por: Elliott, Perry
Publicado: (2023)